Publications du FREGAT Working Group

 

  Articles publiés  

2017

Markar SR, Gronnier C, Pasquer A, Duhamel A, Behal H, Théreaux J, Gagnière J, Lebreton G, Brigand C, Meunier B, Collet D, Mariette C; FREGAT working group – FRENCH – AFC. Surgically treated oesophageal cancer developed in a radiated field: Impact on peri-operative and long-term outcomes. Eur J Cancer. 2017 Apr;75:179-189

 

2016

Pasquer A, Renaud F, Hec F, Gandon A, Vanderbeken M, Drubay V, Caranhac G, Piessen G, Mariette C; FREGAT Working GroupFRENCH. Is Centralization Needed for Esophageal and Gastric Cancer Patients With Low Operative Risk?: A Nationwide Study. Ann Surg. 2016 Nov;264(5):823-830.

 

Voron T, Messager M, Duhamel A, Lefevre JH, Mabrut JY, Goere D, Meunier B, Brigand C, Hamy A, Glehen O, Mariette C, Paye F; On behalf of the FREGAT working group – FRENCH. Is signet-ring cell carcinoma a specific entity among gastric cancers? Gastric Cancer. 2016 Oct;19(4):1027-40

 

Mantziari S, Gronnier C, Pasquer A, Gagnière J, Théreaux J, Demartines N, Schäfer M, Mariette C; FREGAT Working Group–FRENCH–AFC. Incidence and Risk Factors Related to Symptomatic Venous Thromboembolic Events After Esophagectomy for Cancer. Ann Thorac Surg. 2016 Sep;102(3):979-84

 

Bekkar S, Gronnier C, Renaud F, Duhamel A, Pasquer A, Théreaux J, Gagnière J, Meunier B, Collet D, Mariette C; French Eso-Gastric Tumors (FREGAT) working group, Fédération de Recherche EN CHirurgie (FRENCH) and Association Française de Chirurgie (AFC). Multicentre study of neoadjuvant chemotherapy for stage I and II oesophageal cancer. Br J Surg. 2016 Jun;103(7):855-62

 

Markar SR, Gronnier C, Duhamel A, Pasquer A, Théreaux J, Chalret du Rieu M, Lefevre JH, Turner K, Luc G, Mariette C; FREGAT Working Group-FRENCH-AFC. Significance of Microscopically Incomplete Resection Margin After Esophagectomy for Esophageal Cancer. Ann Surg. 2016 Apr;263(4):712-8

 

Markar SR, Gronnier C, Pasquer A, Duhamel A, Beal H, Théreaux J, Gagnière J, Lebreton G, Brigand C, Meunier B, Collet D, Mariette C; French Eso-Gastric Tumors (FREGAT) working group – Federation de Recherche EN CHirurgie (FRENCH) – Association Francaise de Chirurgie (AFC). Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study. Eur J Cancer. 2016 Mar;56:59-68

 

Robb WB, Messager M, Dahan L, Mornex F, Maillard E, D'Journo XB, Triboulet JP, Bedenne L, Seitz JF, Mariette C; Fédération Francophone de Cancérologie Digestive, Société Française de Radiothérapie Oncologique, Union des Centres de Lutte Contre le Cancer, Groupe Coopérateur Multidisciplinaire en Oncologie and the French EsoGAstric Tumour working group - Fédération de Recherche En Chirurgie. Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone. Br J Surg. 2016 Jan;103(1):117-25

 

2015

Markar S, Gronnier C, Duhamel A, Mabrut JY, Bail JP, Carrere N, Lefevre JH, Brigand C, Vaillant JC, Adham M, Msika S, Demartines N, El Nakadi I, Meunier B, Collet D, Mariette C; On behalf of the FREGAT (French Eso-Gastric Tumors) working group, FRENCH (Fédération de Recherche EN CHirurgie), and AFC (Association Française de Chirurgie)The impact of severe anastomotic leak on long-term survival and cancer recurrence after surgical resection for esophageal malignancy. Ann Surg. 2015 Dec;262(6):972-80

 

Luc G, Gronnier C, Lebreton G, Brigand C, Mabrut JY, Bail JP, Meunier B, Collet D, Mariette COn behalf of the FREGAT (French Eso-Gastric Tumors) working group-FRENCH (Fédération de Recherche EN CHirurgie)-AFC (Association Française de Chirurgie)Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study. Ann Surg Oncol2015 Dec;22 Suppl 3:1357-64

 

Piessen G, Lefèvre JH, Cabau M, Duhamel A, Behal H, Perniceni T, Mabrut JY, Regimbeau JM, Bonvalot S, Tiberio GA, Mathonnet M, Regenet N, Guillaud A, Glehen O, Mariani P, Denost Q, Maggiori L, Benhaim L, Manceau G, Mutter D, Bail JP, Meunier B, Porcheron J, Mariette C, Brigand C; AFC and the FREGAT working group. Laparoscopic Versus Open Surgery for Gastric Gastrointestinal Stromal Tumors: What Is the Impact on Postoperative Outcome and Oncologic Results? Ann Surg. 2015 Nov;262(5):831-40

 

Messager M, Pasquer A, Duhamel A, Caranhac G, Piessen G, Mariette C; FREGAT working group - FRENCH. Laparoscopic Gastric Mobilization Reduces Postoperative Mortality After Esophageal Cancer Surgery: A French Nationwide Study. Ann Surg. 2015 Nov;262(5):817-23

 

Markar S, Gronnier C, Duhamel A, Pasquer A, Théreaux J, Chalret du Rieu M, Lefevre JH, Turner K, Luc G, Mariette C ; Written on behalf of the French Eso-Gastric Tumors (FREGAT) Working Group–Fédération de Recherche en Chirurgie (FRENCH)–Association Française de Chirurgie (AFC). Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option? J Clin Oncol2015 Nov 20;33(33):3866-73

 

Robb WB, Messager M, Gronnier C, Tessier W, Hec F, Piessen G, Mariette C; the FREGAT (French EsoGastric Tumor) working group - FRENCH (Fédération de Recherche en Chirurgie). High-Grade Toxicity to Neoadjuvant Treatment for Upper Gastrointestinal Carcinomas: What is the Impact on Perioperative and Oncologic Outcomes? Ann Surg Oncol. 2015 Oct;22(11):3632-9

 

Markar S, Gronnier C, Duhamel A, Bigourdan JM, Badic, B, Chalret du Rieu M, Lefevre JH, Turner K, Luc G, Mariette C; On behalf of the FREGAT working group – FRENCH – AFC. Pattern of postoperative mortality after esophageal cancer resection according to center volume: results from a large European multi-center study. Ann Surg Oncol. 2015 Aug;22(8):2615-23

 

Mariette C, Gronnier C, Duhamel A, Mabrut JY, Bail JP, Carrere N,  Lefevre JH, Meunier B, Collet D, Piessen G; FREGAT working group – FRENCH – AFC. Self-expanding covered metallic stent as a bridge to surgery in esophageal cancer: impact on oncological outcomes. J Am Coll Surg. 2015 Mar;220(3):287-96

 

Robb WB, Bruyere E, Amielh D, Vinatier E, Mabrut JY, Perniceni T, Piessen G, Mariette C; FREGAT Working Group - FRENCH. Esophageal Gastrointestinal Stromal Tumor: Is Tumoral Enucleation a Viable Therapeutic Option? Ann Surg. 2015 Jan;261(1):117-24

 

2014

Piessen G, Messager M, Lefevre JH, Goéré D, Mabrut JY, Meunier B, Brigand C, Hamy A, Glehen O, Mariette C; FREGAT Working Group – FRENCH. Signet ring cell adenocarcinomas: Different clinical-pathological characteristics of oesophageal and gastric locations. Eur J Surg Oncol. 2014 Dec;40(12):1746-55

 

Gronnier C, Tréchot B, Duhamel A, Mabrut JY, Bail JP, Carrere N, Lefevre JH, Brigand C, Vaillant JC, Adham M, Msika S, Demartines N, El Nakadi I, Meunier B, Collet D, Mariette C; On-behalf-of the FREGAT Working Group - FRENCH. Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection: results of a European multicenter study. Ann Surg. 2014 Nov;260(5):764-71

 

Bekkar S, Gronnier C, Messager M, Robb WB, Piessen G, Mariette C; French Eso-Gastric Tumors Working Group - Fédération de Recherche en Chirurgie. The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma. Ann Thorac Surg. 2014 Jan;97(1):303-10

 

2013

Gronnier C, Messager M, Robb WB, Thiebot T, Louis D, Luc G, Piessen G, Mariette C; FREGAT working group - FRENCH. Is the negative prognostic impact of signet ring cell histology maintained in early gastric adenocarcinoma? Surgery. 2013 Nov;154(5):1093-9

 

Robb WB, Messager M, Goere D, Pichot-Delahaye V, Lefevre JH, Louis D, Guiramand J, Kraft K, Mariette C; FREGAT Working Group - FRENCH. Predictive factors of postoperative mortality after junctional and gastric adenocarcinoma resection. JAMA Surg. 2013 Jul;148(7):624-31

 

Mariette C, Bruyère E, Messager M, Pichot-Delahaye V, Paye F, Dumont F, Brachet D, Piessen G; FREGAT Working Group. Palliative Resection for Advanced Gastric and Junctional Adenocarcinoma: Which Patients will Benefit from Surgery? Ann Surg Oncol. 2013 Apr;20(4):1240-9

 

Honoré C, Goéré D, Messager M, Souadka A, Dumont F, Piessen G, Elias D, Mariette C; FREGAT Working Group – FRENCH. Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study. Eur J Surg Oncol. 2013 Mar;39(3):235-41

 

Triboulet JP, Gronnier C, Messager M, Piessen G, Mariette C; FREGAT Working Group. [Does early signet ring cell gastric carcinoma carry a worse prognosis?]. Bull Acad Natl Med. 2013 Feb;197(2):443-55; discussion 455-6. French.

 

2011

Messager M, Lefevre JH, Pichot-Delahaye V, Souadka A, Piessen G, Mariette C; FREGAT working group - FRENCH. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Ann Surg. 2011 Nov;254(5):684-93